Paraoxanase Enzyme Activity in Patients With Pulmonary Diseases
Lung Diseases
About this trial
This is an interventional diagnostic trial for Lung Diseases focused on measuring paraoxonase, lung diseases
Eligibility Criteria
Inclusion Criteria:
- There are not any medical contraindications for fiberoptic bronchoscopy (FOB) and bronchoalveolar lavage(BAL)
- Bronchoscopic symptom does not constitute an impediment status to performing.
- The following method has been obtained in accordance with FOB and BAL material.
Exclusion Criteria:
- The presence of a medical contraindication to FOB and BAL
- During FOB not detecting or not technically making the suitable segment bronchus for BAL
- Not to be duly provided BAL materials.
Inclusion criteria for the control(benign lung diseases) group;
- Have lung disease without malignancy
- The absence of addition disease
- The absence of medical contraindications for FOB and BAL
- The following method has been obtained in accordance with FOB and BAL material. Exclusion criteria for the control group;
1. Detection of a new addition disease or the presence of the addition disease 2. To have a medical contraindication to FOB or BAL 3. Not to be duly provided BAL materials.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Other
Other
Lung Malignancy
Lung bening Diseases
Fiberoptic bronchoscopy was performed under local anaesthesia and sedation for taking Bronchoalveolar Lavage Liq for Paraoxanase activity. Blood samples were taken too. The samples (fine-needle aspiration biopsy and fine-needle aspiration cytology) were diagnosed by pathological examination.
Fiberoptic bronchoscopy was performed under local anaesthesia and sedation for taking Bronchoalveolar Lavage Liq for Paraoxanase activity. Blood samples were taken too.